Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders
- 1 December 2017
- journal article
- Published by Elsevier in Kidney International
- Vol. 92 (6) , 1493-1506
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Targeted Exome Sequencing Integrated with Clinicopathological Information Reveals Novel and Rare Mutations in Atypical, Suspected and Unknown Cases of Alport Syndrome or ProteinuriaPLOS ONE, 2013
- Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32PLOS ONE, 2013
- Recessive mutations in DGKE cause atypical hemolytic-uremic syndromeNature Genetics, 2013
- Copy-Number Disorders Are a Common Cause of Congenital Kidney MalformationsThe American Journal of Human Genetics, 2012
- High-throughput mutation analysis in patients with a nephronophthisis-associated ciliopathy applying multiplexed barcoded array-based PCR amplification and next-generation sequencingJournal of Medical Genetics, 2012
- Deep phenotyping for precision medicineHuman Mutation, 2012
- DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndromePediatric Nephrology, 2010
- A new strategic phase for genomic medicine in UK health servicesGenome Medicine, 2009
- COL4A3/COL4A4 Mutations Producing Focal Segmental Glomerulosclerosis and Renal Failure in Thin Basement Membrane NephropathyJournal of the American Society of Nephrology, 2007
- Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic SyndromePLOS Genetics, 2007